IMRT and IGRT in head and neck cancer: Have we delivered what we promised?

Indian Journal of Surgical Oncology

Volumn 1, Issue 2, 2010, Pages 166-185

  Tejpal, Gupta ^a   JaiPrakash, Agarwal ^a   Susovan, Bannerjee ^a   Ghosh Laskar, Sarbani ^a   Murthy, Vedang ^a   Budrukkar, Ashwini ^a  

^a TATA MEMORIAL HOSPITAL   (India)

Author keywords

head neck cancer; IGRT; IMRT; outcomes

Indexed keywords

BLEEDING; BONE NECROSIS; BRAIN NECROSIS; CANCER CONTROL; CANCER RADIOTHERAPY; CANCER SURVIVAL; CLINICAL PRACTICE; DISEASE FREE SURVIVAL; DISTANT METASTASIS FREE SURVIVAL; DOSIMETRY; DYSPHAGIA; EXTERNAL BEAM RADIOTHERAPY; FASCIITIS; FIBROSIS; FOLLOW UP; HADRON; HEAD AND NECK CANCER; HEALTH CARE DELIVERY; HEALTH CARE QUALITY; HEARING LOSS; HOARSENESS; HUMAN; IMAGE GUIDED RADIOTHERAPY; INTENSITY MODULATED RADIATION THERAPY; MOLECULAR IMAGING; NASOPHARYNX CANCER; NECROSIS; OUTCOME ASSESSMENT; OVERALL SURVIVAL; PERCUTANEOUS ENDOSCOPIC GASTROSTOMY; PRIORITY JOURNAL; PROGRESSION FREE SURVIVAL; QUALITY OF LIFE; RADIATION DOSE; RADIATION DOSE FRACTIONATION; RADIATION INJURY; RADIOSURGERY; REVIEW; TREATMENT FAILURE; TREATMENT PLANNING; TRISMUS; TUMOR VOLUME; XEROSTOMIA;

EID: 84862839561     PISSN: 09757651     EISSN: 09766952     Source Type: Journal    
DOI: 10.1007/s13193-010-0030-x     Document Type: Review

References (100)

1. Delany G, Jacob S, Barton M. Estimation of an optimal external beam radiotherapy utilization rate for head and neck carcinoma. Cancer. 2005; 103: 2216-2227.
2. Trotti A. Toxicities in head and neck cancers: a review of trends and issues. Int J Radiat Oncol Biol Phys. 2000; 47: 1-12.
3. Trotti A, Bellm LA, Epstein JB, Frame D, Fuchs HJ, Gwede CK, et al. Mucositis incidence, severity and associated outcomes in patients with head and neck cancer receiving radiotherapy with or without chemotherapy: A systemic literature review. Radiother Oncol. 2003; 66: 253-262.
4. Langendijk JA, Doornaert P, Verdonck-de Leeuw IM, Leemans CR, Aaronson NK, Slotman BJ. Impact of late treatment-related toxicity on quality of life among patients with head and neck cancer treated with radiotherapy. J Clin Oncol. 2008; 26: 3770-3776.
5. Bernier J, Hall AJ, Giaccia A. Radiation oncology: a century of achievements. Nat Rev Cancer. 2004; 4: 737-747.
6. Gregoire V, De Neve W, Eisbruch A, Lee N, van den Weyngaert D, van Gestel D. Intensity-modulated radiation therapy for head and neck carcinoma. Oncologist 2007; 12: 555-564.
7. Intensity Modulated Radiation Therapy CollaborativeWorking Group. Intensity-modulated radiotherapy: Current status and issues of interest. Int J Radiat Oncol Biol Phys. 2001; 51: 880-914.
8. Ezzell GA, Galvin JM, Low D, Palta JR, Rosen I, Sharpe MB, et al. Guidance document on delivery, treatment planning, and implementation of IMRT: Report of the IMRT subcommittee of the AAPM Radiation Therapy committee. Med Phys. 2003; 30: 2089-2115.
9. Hartford AC, Palisca MG, Eichler TJ, Beyer DC, Devineni VR, Ibbot GS, et al. American Society for Therapeutic Radiology and Oncology (ASTRO) and American College of Radiology (ACR) practice guidelines for Intensity-Modulated Radiation Therapy (IMRT). Int J Radiat Oncol Biol Phys. 2009; 73: 9-14.
10. Jaffray D, Kupelian P, Djemil T, Macklis RM. Review of imageguided radiation therapy. Expert Rev Anticancer Ther. 2007: 7: 89-103.
11. Nath SK, Simpson DR, Rose BS, Sandhu AP. Recent advances in image-guided radiotherapy for head and neck carcinoma. J Oncol. 2009; 2009: 752135.
12. Mendenhall WM, Amdur RJ, Palta JR. Intensity-modulated radiotherapy in the standard management of head and neck cancer: promises and pitfalls. J Clin Oncol. 2006; 24: 2618-2623.
13. Veldeman L, Madani I, Hulstaert F, De Meerleer G, Mareel M, De Neve W. Evidence behind use of intensity-modulated radiotherapy: a systematic review of comparative clinical studies. Lancet Oncol. 2008; 9: 367-375.
14. International Commission on Radiation Units and Measurements. Prescribing, recording and reporting photon beam therapy. Bethesda, MD: ICRU; 1993.
15. International Commission on Radiation Units and Measurements. Prescribing, recording and reporting photon beam therapy (supplement to ICRU Report 50). Bethesda, MD: ICRU; 1999.
16. Palta JR, Liu C, Li JG. Quality assurance of intensity-modulated radiation therapy. Int J Radiat Oncol Biol Phys. 2008; 71(suppl): S108-S112.
17. Chao KS, Ozygit G, Tran B, Chengiz M, Dempsey JF, Low DA. Patterns of failure in patients receiving definitive and postoperative IMRT for head and neck cancer. Int J Radiat Oncol Biol Phys. 2003; 55: 312-321.
18. Lee N, Xia P, Fischbein NJ, Akazawa P, Akazawa C, Quivey JM. Intensity-modulated radiation therapy for head-and-neck cancer: the UCSF experience focusing on target volume delineation. Int J Radiat Oncol Biol Phys. 2003; 57: 49-60.
19. Eisbruch A, Marsh LH, Dawson LA, Bradford CR, Teknos TN, Chepeha DB, et al. Recurrences near base of skull after IMRT for head and neck cancer: implications for target delineation in high neck and for parotid sparing. Int J Radiat Oncol Biol Phys. 2004; 59: 28-42.
20. Yao M, Dornfeld KJ, Buatti JM, Skwarchuk M, Tan H, Nguyen T, et al. Intensity-modulated radiation treatment for head-and-neck squamous cell carcinoma-the University of Iowa experience. Int J Radiat Oncol Biol Phys. 2005; 63: 410-421.
21. Studer G, Huguenin PU, Davis JB, Kunz G, Lutolf UM, Glanzmann C. IMRT using simultaneous integrated boost (SIB) in head and neck cancer patients. Radiat Oncol. 2006; 1: 7.
22. Schoenfeld GO, Amdur RJ, Morris CG, Li JG, Hinerman RW, Mendenhall WM. Patterns of failure and toxicity after intensity-modulated radiotherapy for head and neck cancer. Int J Radiat Oncol Biol Phys. 2008; 71: 377-385.
23. Lee N, Xia P, Quivey JM, Sultanem K, Poon I, Akazawa C, et al. Intensity-modulated radiotherapy in the treatment of nasopharyngeal carcinoma: An update of the UCSF experience. Int J Radiat Oncol Biol Phys. 2002; 53: 12-22.
24. Chong Z. Improved local control with intensity-modulated radiation therapy in patients with nasopharyngeal carcinoma. Int J Radiat Oncol Biol Phys. 2004; 60(suppl): S317.
25. Bucci M, Xia P, Lee N, Fishbein N, Kramer A, Weinberg V, et al. Intensity-modulated radiation therapy for carcinoma of the nasopharynx: An update of the UCSF experience. Int J Radiat Oncol Biol Phys. 2004; 60(suppl): S317-S318.
26. Zhao C, Lu L, Han F, Huang S, Lin C, Deng T, et al. Preliminary results of Intensity modulated radiotherapy alone for 122 patients with untreated nasopharyngeal carcinoma. Int J Radiat Oncol Biol Phys. 2005; 63(suppl): S382.
27. Kam MK, Teo PM, Chau RM, Cheung KY, Choi PH, Kwan WH, et al. Treatment of nasopharyngeal carcinoma with intensity-modulated radiotherapy: The Hong Kong experience. Int J Radiat Oncol Biol Phys. 2004; 60: 1440-1450.
28. Kwong DL, Pow EH, Sham JS, McMillan AS, Leung LHT, Leung WK, et al. Intensity-modulated radiotherapy for early-stage nasopharyngeal carcinoma: A prospective study on disease control and preservation of salivary function. Cancer 2004; 101: 1584-1593.
29. Wolden SL, Chen WC, Pfister DG, Kraus DH, Berry SL, Zelefsky MJ. Intensity-modulated radiation therapy (IMRT) for nasopharynx cancer: Update of the Memorial Sloan-Kettering experience. Int J Radiat Oncol Biol Phys. 2006; 64: 57-62.
30. Fang FM, Chien CY, Tsai WL, Chen HC, Hsu HC, Lui CC, et al Quality of life and survival outcome for patients with nasopharyngeal carcinoma receiving threedimensional conformal radiotherapy vs intensity-modulated radiotherapy - a longitudinal study. Int J Radiat Oncol Biol Phys. 2008; 72: 356-364.
31. Chao KS, Ozyigit G, Blanco AI, Thorstad WL, Deasy JO, Haughey BH, et al. Intensity-modulated radiation therapy for oropharyngeal carcinoma: impact of tumor volume. Int J Radiat Oncol Biol Phys. 2004; 59: 43-50.
32. Lee NY, de Arruda FF, Puri DR, Wolden SL, Narayana A, Mechalakos J, et al. A comparison of intensity-modulated radiation therapy and concomitant boost radiotherapy in the setting of concurrent chemotherapy for locally advanced oropharyngeal carcinoma. Int J Radiat Oncol Biol Phys. 2006; 66: 966-974.
33. de Arruda FF, Puri DR, Zhung J, Narayana A, Wolden S, Hunt M, et al. Intensity-modulated radiation therapy for the treatment of oropharyngeal carcinoma: The Memorial Sloan-Kettering Cancer Center experience. Int J Radiat Oncol Biol Phys. 2006; 64: 363-373.
34. Garden AS, Morrison WH, Wong PF, Tung SS, Rosenthal DI, Dong L, et al. Disease-control rates following intensity-modulated radiation therapy for small primary oropharyngeal carcinoma. Int J Radiat Oncol Biol Phys. 2007; 67: 438-444.
35. Huang K, Xia P, Chuang C, Weinberg V, Glastonbury CM, Eisele DW, et al. Intensity-modulated chemo-radiation for treatment of stage III-IV oropharyngeal carcinoma. Cancer. 2008; 113: 497-507.
36. Sanguineti G, Brandon Gunn G, Endres EJ, Chaljub G, Cheruvu P, Parker B. Patterns of loco-regional failure after exclusive IMRT for oropharyngeal carcinoma. Int J Radiat Oncol Biol Phys. 2008; 72: 737-746.
37. Daly ME, Le QT, Maxim PG, Loo BW, Kaplan MJ, Fischbein NJ, et al. Intensity-modulated Radiotherapy in the Treatment of Oropharyngeal Cancer: Clinical Outcomes and Patterns of Failure. Int J Radiat Oncol Biol Phys. 2009 (in press).
38. Studer G, Zwahlen RA, Graetz KW, Davis BJ, Glanzmann C. IMRT in oral cavity cancer. Radiat Oncol. 2007; 2: 16.
39. Yao M, Chang K, Funk GF, Lu H, Tan H, Wacha J, et al. The failure patterns of oral cavity squamous cell carcinoma after intensity-modulated radiotherapy - the University of Iowa experience. Int J Radiat Oncol Biol Phys. 2007; 67: 1332-1341.
40. Studer G, Lutolf UM, Davis JB, and Glanzmann C. IMRT in hypopharyngeal tumors. Strahlenther Onkol. 2006; 182: 331-335.
41. Lee NY, O'Meara W, Chan K, Della-Bianca C, Mechalakos JG, Zhung J, et al. Concurrent chemotherapy and intensity-modulated radiotherapy for loco-regionally advanced laryngeal and hypopharyngeal cancers. Int J Radiat Oncol Biol Phys. 2007; 69: 459-468.
42. Claus F, Boterberg T, Ost P, De Neve W. Short term toxicity profile for 32 sino-nasal tumors patients treated with IMRT: Can we avoid dry eye syndrome? Radiother Oncol. 2002; 64: 205-208.
43. Duthoy W, Boterberg T, Claus F, Ost P, Vakaet L, Bral S, et al. Postoperative intensity-modulated radiotherapy in sino-nasal carcinoma: Clinical results in 39 patients. Cancer 2005; 104: 71-82.
44. Combs SE, Konkel S, Schulz-Ertner D, Munter MW, Debus J, Huber PE, et al. Intensity-modulated radiotherapy (IMRT) in patients with carcinomas of the paranasal sinuses: Clinical benefit for complex shaped target volumes. Radiat Oncol. 2006; 1: 23.
45. Chen AM, Daly ME, Bucci MK, Xia P, Akazawa C, Quivey JM, et al. Carcinomas of the paranasal sinuses and nasal cavity treated with radiotherapy at a single institution over five decades: Are we making improvement? Int J Radiat Oncol Biol Phys. 2007; 69: 141-147.
46. Daly ME, Chen AM, Bucci MK, EI-Sayed I, Xia P, Laplan MJ, et al. Intensity-modulated radiation therapy for malignancies of the nasal cavity and paranasal sinuses. Int J Radiat Oncol Biol Phys. 2007; 67: 151-157.
47. Hoppe BS, Stegman LD, Zelefsky MJ, Rosenzweig KE, Wolden SL, Patel SG, et al. Treatment of nasal cavity and paranasal sinus cancer with modern radiotherapy techniques in the postoperative setting- The MSKCC experience. Int J Radiat Oncol Biol Phys. 2007; 67: 691-702.
48. Dirix P, Nuyts S, Vanstraelen B, Nulens A, Hermans R, Jorissen M, et al. Postoperative intensitymodulated radiotherapy for malignancies of the nasal cavity and paranasal sinuses. Radiother Oncol. 2007; 69: 1042-1050.
49. Madani I, Bonte K, Vakaet L, Boterberg T, De Neve W. Intensitymodulated radiotherapy for sinonasal tumors: Ghent University Hospital update. Int J Radiat Oncol Biol Phys. 2009; 73: 424-432.
50. Lu TX, Mai WY, Teh BS, Zhao C, Han F, Huang Y, et al. Initial experience using intensity-modulated radiotherapy for recurrent nasopharyngeal carcinoma. Int J Radiat Oncol Biol Phys. 2004; 58: 682-687.
51. Biagioli M, Harvey M, Roman E, Raez LE, Wolfson AH, Mutyala S, et al. Intensity-modulated radiotherapy with concurrent chemotherapy for previously irradiated, recurrent head and neck cancers. Int J Radiat Oncol Biol Phys. 2007; 69: 1067-1073.
52. Lee N, Chan K, Bekelman JE, Zhung J, Mechalakos J, Narayana A, et al. Salvage re-irradiation for recurrent head and neck cancers. Int J Radiat Oncol Biol Phys. 2007; 68: 731-740.
53. Sulman EP, Schwartz DL, Le TT, Ang KK, Morrison WH, Rosenthal DI, et al. IMRT re-irradiation for head and neck cancers: disease control and morbidity outcomes. Int J Radiat Oncol Biol Phys. 2009; 73: 399-409.
54. Duprez F, Madani I, Bonte K, Boterberg T, Vakaet L, Derie C, et al. Intensity-modulated radiotherapy for recurrent and second primary head and neck cancer in previously irradiated territory. Radiother Oncol. 2009; 93: 563-569.
55. Madani I, Vakaet L, Bonte K, Boterberg T, De Neve W. Intensitymodulated radiotherapy for cervical lymph node metastasis from unknown primary cancer. Int J Radiat Oncol Biol Phys. 2008; 71: 1158-1166.
56. Klem ML, Mechalakos JG, Wolden SL, Zelefsky MJ, Singh B, Kraus D, et al. Intensity-modulated radiotherapy for head neck cancer of unknown primary: toxicity and preliminary efficacy. Int J Radiat Oncol Biol Phys. 2008; 70: 1100-1107.
57. Lu H, Yao M, Tan H. Unknown primary head and neck cancer treated with intensity-modulated radiotherapy: to what extent the volume should be irradiated. Oral Oncol. 2009; 45: 474-479.
58. Rosenbluth BD, Serrano V, Happersett L, Shaha AR, Tuttle MR, Narayana A, et al. Intensity-modulated radiotherapy for the treatment of non-anaplastic thyroid cancer. Int J Radiat Oncol Biol Phys. 2005; 63: 1419-1426.
59. Urbano TG, Clark CH, Hansen VN, Adams EJ, Miles EA, Nair HM, et al. Intensity modulated radiotherapy (IMRT) in locally advanced thyroid cancer: acute toxicity results of a Phase I study. Radiother Oncol. 2007; 85: 58-63.
60. Schwartz DL, Lobo MJ, Ang KK, Morrison WH, Rosenthal DI, Ahamad A, et al. Postoperative external beam radiotherapy for differentiated thyroid cancer: Outcome and morbidity with conformal therapy. Int J Radiat Oncol Biol. 2009; 74: 1083-1091.
61. Eisbruch A, Harris J, Garden AS, Chao CKS, Straube W, Harari PM, et al. Multiinstitutional trial of accelerated hypofractionated intensity modulated radiation therapy for early oropharyngeal cancer (RTOG-00-22). Int J Radiat Oncol Biol Phys. 2009 (in press).
62. Lee N, Harris J, Garden AS, Straube W, Glissin B, Xia P, et al. Intensity-modulated radiotherapy with or without chemotherapy for nasopharyngeal carcinoma: Radiation Therapy Oncology Group phase II trial 0225. J Clin Oncol. 2009; 27: 3684-3690.
63. Lin S, Pan J, Han L, Zhang X, Liao X, and Lu JJ. Nasopharyngeal carcinoma treated with reducedvolume intensity-modulated radiation therapy: report on the 3-year outcome of a prospective series. Int J Radiat Oncol Biol Phys. 2009; 75: 1071-1078.
64. Zhang Y, Lin ZA, Pan JJ, Zheng Z, Yang L, Lin SJ, et al. Concurrent control study of different radiotherapy for primary nasopharyngeal carcinoma intensity modulated radiotherapy versus conventional radiotherapy. Chin J Cancer 2009; 28: 1143-1148.
65. Vergeer MR, Doornaert PA H, Rietveld DHF, Leemans CR, Slotman BJ, Langendijk JA. Intensitymodulated radiotherapy reduces radiation induced morbidity and improves health related quality of life: results of a non-randomized prospective study using standardized follow-up program. Int J Radiat Oncol Biol Phys. 2009; 74: 1-8.
66. Pow EHN, Kwong DLW, Macmillan AS, Wong MCM, Sham JST, Leung LHT, et al. Xerostomia and quality of life after intensity modulated radiotherapy vs conventional radiotherapy for early-stage nasopharyngeal carcinoma. Initial report on a randomized controlled trial. Int J Radiat Oncol Biol Phys. 2006; 66: 981-991.
67. Kam MKM, Leung SF, Zee B, Chau RMC, Suen JSJ, Mo F, et al. Prospective randomized study of intensity modulated radiotherapy on salivary gland function in early-stage nasopharyngeal carcinoma patients. J Clin Oncol 2007; 25: 4873-4879.
68. Nutting C, A'Hern R, Rogers MS, Syndenham MA, Adab F, Harrington K, et al. First results of a phase III multicentre randomized controlled trial of intensity modulated (IMRT) versus conventional radiotherapy (RT) in head and neck cancer (PARSPORT: ISRCTN 48243537; CRUK/03/005). J Clin Oncol 2009; 27: s18 (suppl; abstr LBA6006).
69. Nangia S, Chufal KS, Tyagi A, Bhatnagar A, Mishra M, Ghosh D. Selective nodal irradiation for head and neck cancer using intensitymodulated radiotherapy: application of RTOG consensus guideline in routine clinical practice. Int J Radiat Oncol Biol Phys. 2010; 76: 146-153.
70. Grégoire V, Levendag P, Ang KK, Bernier J, Braaksma M, Budach V, et al. CT-based delineation of lymph node levels and related CTVs in the node-negative neck: DAHANCA, EORTC, GORTEC, NCIC, RTOG consensus guidelines. Radiother Oncol. 2003; 69: 227-236.
71. Gregoire V, Eisbruch A, Hamoir M, Levandag P. Proposal for the delineation of the nodal CTV in the node-positive and post-operative neck. Radiother Oncol. 2006; 79: 15-20.
72. Cannon DM, Lee NY. Recurrence in region of spared parotid gland after definitive intensity-modulated radiotherapy for head neck cancer. Int J Radiat Oncol Biol Phys. 2008; 70: 660-665.
73. Lee N, Mechalakos J, Puri DR, Hunt M. Choosing an intensitymodulated radiation therapy technique in the treatment of head-andneck cancer. Int J Radiat Oncol Biol Phys. 2007; 68: 1299-1309.
74. Longobardi B, De ME, Fiorino C, Delloca I, Broggi S, Cattaneo GM, Calandrino R. Comparing 3D-CRT and inversely optimized IMRT planning for head and neck cancer: equivalence between step-and-shoot and sliding window technique. Radiother Oncol. 2005: 77: 148-56.
75. Chui CS, Chan MF, Yorke E, Spirou S, Ling CC. Delivery of intensity-modulated radiation therapy with a conventional multi-leafcollimator: comparison of dynamic and segmental methods. Med Phys. 2001; 28: 2441-2449.
76. Chen AM, Jennelle RL, Sreeraman R, Yang CC, Liu T, Vijayakumar S, et al. Initial clinical experience with helical tomotherapy for head and neck cancer. Head Neck 2009; 31: 1571-1578.
77. Vanetti E, Clivo A, Nicolini G, Fogliata A, Ghosh-Laskar S, Agarwal JP, et al. Volometcic modulated arc radiotherapy for carcinomas of the oro-pharymx, hypopharynx and larynx: A treatment planning comparison with fixed-field IMRT. Radiother Oncol. 2009; 92: 111-117.
78. Bedford JL. Treatment planning for volumetric modulated arc therapy. Med Phys. 2009; 36: 5128-5138.
79. Ho KF, Fowler JF, Sykes AJ, Yap BK, Lee LW, Slevin NJ. IMRT dose fractionation for head neck cancer: variation in current approaches will make standardization difficult. Acta Oncol. 2009; 48: 431-439.
80. Chan AW and Liebsch NJ. Proton radiation therapy for head and neck cancer. J Surg Oncol. 2008; 97: 697-700.
81. Douglas JG, Koh WJ, Austin-Seymour M, Laramore GE. Treatment of salivary gland neoplasms with fast neutron radiotherapy. Arch Otolaryngol Head Neck Surg. 2003; 129: 944-948.
82. Siddiqui F, Patel M, Khan M, McLean S, Dragovic J, Jin JY, et al. Stereotactic body radiation therapy for primary, recurrent, and metastatic tumors in the head and neck region. Int J Radiat Oncol Biol Phys. 2009; 74: 1047-1053.
83. Rwigema JC, Heron DE, Ferris RL, Gibson M, Quinn A, Yang Y, et al. Fractionated stereotactic body radiation therapy in the treatment of previously-irradiated recurrent head and neck carcinoma: Updated report of the university of Pittsburgh experience. Am J Clin Oncol. 2009 (in press).
84. Roh KW, Jang JS, Kim MS, Sun DI, Kim BS, Jung SL, et al. Fractionated stereotactic radiotherapy as re-irradiation for locally recurrent head and neck cancers. Int J Radiat Oncol Biol Phys. 2009; 74: 1348-1355.
85. Gupta T, Chopra S, Kadam A, Agarwal JP, Devi PR, Ghosh-Laskar S, et al. Assessment of three-dimensional set-up errors in conventional head and neck radiotherapy using electronic portal imaging device. Radiat Oncol. 2007; 2: 44.
86. Zeidan OA, Langen KM, Meeks SL, Manon RR, Wagner TH, Willoughby TR, et al. Evaluation of image-guided protocols in treatment of head and neck cancers. Int J Radiat Oncol Biol Phys. 2007; 67: 670-677.
87. Schubert LK, Tome WA, Meheta MP, Soisson ET, Mackie TR, Ritter MA, et al. A comprehensive assessment by tumor site of patient set-up using daily MVCT imaging from more than 3, 800 helical tomotherapy treatments. Int J Radiat Oncol Biol Phys. 2009; 73: 1260-1269.
88. Miles EA, Clark CH, Urbano MT, Bidmead M, Dearnelay DP, Harrington KJ, et al. The impact of introducing intensity-modulated radiotherapy into routine clinical practice. Radiother Oncol 2005; 77: 241-246.
89. Murthy V, Gupta T, Kadam A, Ghosh-Laskar S, Budrukkar A, Phurailatpam R, et al. Time trial: A prospective comparative study of the time-resource burden for threedimensional conformal radiotherapy and intensity-modulated radiotherapy in head and neck cancers. J Can Res Ther. 2009; 5: 107-112.
90. Bijdekerke P, Verellen D, Tournel K, Vinh-Hung V, Somers F, Bieseman P, et al. Tomotherapy: implications on daily workload and scheduling patients. Radiother Oncol. 2008; 86: 224-230.
91. Ford EC, Herman J, Yorke E, Wahl RL. 18F-FDG PET/CT for imageguided and intensity-modulated radiotherapy. J Nucl Med. 2009; 50: 1655-1665.
92. Rothschild S, Studer G, Seifert B, Huguenin P, Glanzmann C, Davis JB, et al. PET/CT staging followed by Intensity-Modulated Radiation Therapy (IMRT) improves treatment outcome of locally advanced pharyngeal carcinoma: a matchedpair comparison. Radiat Oncol. 2007; 2: 22.
93. Vernon MR, Maheshwari M, Schultz CJ, Michel Michelle A, Wong SJ, Campbell BH, et al. Clinical outcomes of patients receiving integrated PET/CT-guided radiotherapy for head and neck carcinoma. Int J Radiat Oncol Biol Phys. 2008; 70: 768-684.
94. Bentzen SM. Dose painting and theragnostic imaging: biologically targeted dose distributions in external beam radiation oncology. Cancer Treat Res. 2008; 139: 41-62.
95. Barker JL, Garden AS, Ang KK, O'Daniel JC, Wang H, Court LE, et al. Quantification of volumetric and geometric changes occurring during fractionated radiotherapy for head-and-neck cancer using an integrated CT/Linear accelerator system. Int J Radiat Oncol Biol Phys. 2004; 59: 960-970.
96. Hansen EK, Bucci MK, Quivey JM, Weinberg V, Xia P. Repeat CT imaging and re-planning during the course of IMRT for head-and-neck cancer. Int J Radiat Oncol Biol Phys. 2006; 64: 355-362.
97. Kuo YC, Wu TH, Chung TS, Huang KW, Chao KS, Su WC, et al. Effect of regression of enlarged neck lymph nodes on radiation doses received by parotid glands during intensity-modulated radiotherapy for head-and-neck cancer. Am J Clin Oncol. 2006; 29: 600-605.
98. O'Daniel JC, Garden AS, Schwartz DL, Wang H, Ang KK, Ahamad A, et al. Parotid gland dose in intensity-modulated radiotherapy for head and neck cancer: is what you plan what you get? Int J Radiat Oncol Biol Phys. 2007; 69: 1290-1296.
99. Lee C, Langen KM, Lu W, Haimerl J, Schnarr E, Ruchala KJ, et al. Assessment of parotid gland dose changes during head and neck cancer radiotherapy using daily megavoltage computed tomography and deformable image registration. Int J Radiat Oncol Biol Phys. 2008; 71: 1563-1571.
100. Blanco AI, Chao KS, EI Naqa I, Franklin GE, Zakarian K, Vicic M, et al. Dose-volume modeling of salivary function in patients with head-and-neck cancer receiving radiotherapy. Int J Radiat Oncol Biol Phys. 2005; 62: 1055-1069.